200 related articles for article (PubMed ID: 32303804)
1. Risk assessment for humans using physiologically based pharmacokinetic model of diethyl phthalate and its major metabolite, monoethyl phthalate.
Jeong SH; Jang JH; Cho HY; Lee YB
Arch Toxicol; 2020 Jul; 94(7):2377-2400. PubMed ID: 32303804
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of diethyl phthalate and its major metabolite, monoethyl phthalate, in rat plasma, urine, and various tissues collected from a toxicokinetic study by ultrahigh performance liquid chromatography-tandem mass spectrometry.
Jeong SH; Jang JH; Cho HY; Lee YB
J Pharm Biomed Anal; 2019 Sep; 173():108-119. PubMed ID: 31125947
[TBL] [Abstract][Full Text] [Related]
3. Human risk assessment of di-isobutyl phthalate through the application of a developed physiologically based pharmacokinetic model of di-isobutyl phthalate and its major metabolite mono-isobutyl phthalate.
Jeong SH; Jang JH; Cho HY; Lee YB
Arch Toxicol; 2021 Jul; 95(7):2385-2402. PubMed ID: 33907876
[TBL] [Abstract][Full Text] [Related]
4. A physiologically based pharmacokinetic model of diethyl phthalates in humans.
Chen S; Shi Z; Zhang Q
Environ Pollut; 2024 Jan; 340(Pt 1):122849. PubMed ID: 37926418
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, metabolism and excretion of 14C-monoethyl phthalate (MEP) and 14C-diethyl phthalate (DEP) after single oral and IV administration in the juvenile dog.
Kao ML; Ruoff B; Bower N; Aoki T; Smart C; Mannens G
Xenobiotica; 2012 Apr; 42(4):389-97. PubMed ID: 22054055
[TBL] [Abstract][Full Text] [Related]
6. Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: Application to health risk assessment.
Hu M; Zhang Y; Zhan M; He G; Qu W; Zhou Y
Chemosphere; 2022 Nov; 307(Pt 2):135931. PubMed ID: 35940406
[TBL] [Abstract][Full Text] [Related]
7. Steady-State Human Pharmacokinetics of Monobutyl Phthalate Predicted by Physiologically Based Pharmacokinetic Modeling Using Single-Dose Data from Humanized-Liver Mice Orally Administered with Dibutyl Phthalate.
Miura T; Uehara S; Mizuno S; Yoshizawa M; Murayama N; Kamiya Y; Shimizu M; Suemizu H; Yamazaki H
Chem Res Toxicol; 2019 Feb; 32(2):333-340. PubMed ID: 30652481
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model.
Kim SJ; Shin H; Lee YB; Cho HY
Arch Toxicol; 2018 Mar; 92(3):1113-1131. PubMed ID: 29143853
[TBL] [Abstract][Full Text] [Related]
9. Hazards of diethyl phthalate (DEP) exposure: A systematic review of animal toxicology studies.
Weaver JA; Beverly BEJ; Keshava N; Mudipalli A; Arzuaga X; Cai C; Hotchkiss AK; Makris SL; Yost EE
Environ Int; 2020 Dec; 145():105848. PubMed ID: 32958228
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion and daily intake rates of diethyl phthalate in the general Canadian population.
Saravanabhavan G; Walker M; Guay M; Aylward L
Sci Total Environ; 2014 Dec; 500-501():191-8. PubMed ID: 25217994
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics of diisobutyl phthalate and its major metabolite, monoisobutyl phthalate, in rats: UPLC-ESI-MS/MS method development for the simultaneous determination of diisobutyl phthalate and its major metabolite, monoisobutyl phthalate, in rat plasma, urine, feces, and 11 various tissues collected from a toxicokinetic study.
Jeong SH; Jang JH; Cho HY; Lee YB
Food Chem Toxicol; 2020 Nov; 145():111747. PubMed ID: 32926938
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of phthalate metabolites in human urine from several Asian countries.
Guo Y; Alomirah H; Cho HS; Minh TB; Mohd MA; Nakata H; Kannan K
Environ Sci Technol; 2011 Apr; 45(7):3138-44. PubMed ID: 21395215
[TBL] [Abstract][Full Text] [Related]
13. Biomonitoring of phthalate metabolites in the Canadian population through the Canadian Health Measures Survey (2007-2009).
Saravanabhavan G; Guay M; Langlois É; Giroux S; Murray J; Haines D
Int J Hyg Environ Health; 2013 Nov; 216(6):652-61. PubMed ID: 23419587
[TBL] [Abstract][Full Text] [Related]
14. Female exposure to phthalates and time to pregnancy: a first pregnancy planner study.
Thomsen AM; Riis AH; Olsen J; Jönsson BA; Lindh CH; Hjollund NH; Jensen TK; Bonde JP; Toft G
Hum Reprod; 2017 Jan; 32(1):232-238. PubMed ID: 27852689
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles for low-dose exposure to diethyl phthalate in rodents and humans: a translational study with implications for breast carcinogenesis.
Gopalakrishnan K; Aushev VN; Manservisi F; Falcioni L; Panzacchi S; Belpoggi F; Parada H; Garbowski G; Hibshoosh H; Santella RM; Gammon MD; Teitelbaum SL; Chen J
Sci Rep; 2020 Apr; 10(1):7067. PubMed ID: 32341500
[TBL] [Abstract][Full Text] [Related]
16. Estimated daily intake of phthalates in occupationally exposed groups.
Hines CJ; Hopf NB; Deddens JA; Silva MJ; Calafat AM
J Expo Sci Environ Epidemiol; 2011; 21(2):133-41. PubMed ID: 20010977
[TBL] [Abstract][Full Text] [Related]
17. Phthalates in cosmetic and personal care products: concentrations and possible dermal exposure.
Koniecki D; Wang R; Moody RP; Zhu J
Environ Res; 2011 Apr; 111(3):329-36. PubMed ID: 21315328
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans.
Janjua NR; Frederiksen H; Skakkebaek NE; Wulf HC; Andersson AM
Int J Androl; 2008 Apr; 31(2):118-30. PubMed ID: 18194284
[TBL] [Abstract][Full Text] [Related]
19. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
[TBL] [Abstract][Full Text] [Related]
20. A margin of exposure approach to assessment of non-cancerous risk of diethyl phthalate based on human exposure from bottled water consumption.
Zare Jeddi M; Rastkari N; Ahmadkhaniha R; Yunesian M; Nabizadeh R; Daryabeygi R
Environ Sci Pollut Res Int; 2015 Dec; 22(24):19518-28. PubMed ID: 26263883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
